| academic journal | Q737498 |
| open-access journal | Q773668 |
| society journal | Q73364223 |
| P6981 | ACNP journal ID | 3214172 |
| P8375 | Crossref journal ID | 298972 |
| P5115 | Directory of Open Access Journals ID | 2380-6761 |
| P236 | ISSN | 2380-6761 |
| P7363 | ISSN-L | 2380-6761 |
| P1055 | NLM Unique ID | 101689146 |
| P856 | official website | https://onlinelibrary.wiley.com/journal/23806761 |
| P10283 | OpenAlex ID | S4210212656 |
| P12834 | PMC journal ID | 3332 |
| P7662 | Scilit journal ID | 2725326 |
| P12897 | Wiley Online Library journal ID | 23806761 |
| P972 | catalog | Directory of Open Access Journals | Q1227538 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P17 | country | United States of America | Q30 |
| P495 | country of origin | United States of America | Q30 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemical engineering | Q83588 |
| P123 | publisher | Wiley | Q1479654 |
| P1476 | title | Bioengineering & translational medicine |
| Q93091714 | "Locked" cancer cells are more sensitive to chemotherapy |
| Q92983342 | 2D or 3D? How cell motility measurements are conserved across dimensions in vitro and translate in vivo |
| Q121598845 | A drug‐selectable acoustic reporter gene system for human cell ultrasound imaging |
| Q113191749 | A ferret brain slice model of oxygen–glucose deprivation captures regional responses to perinatal injury and treatment associated with specific microglial phenotypes |
| Q64887581 | A microfluidic model of human brain (μHuB) for assessment of blood brain barrier. |
| Q125061015 | A novel soft cardiac assist device based on a dielectric elastomer augmented aorta: An in vivo study |
| Q58126740 | A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease |
| Q95643280 | A self-adhesive microneedle patch with drug loading capability through swelling effect |
| Q129663555 | AI‐organoid integrated systems for biomedical studies and applications |
| Q113402478 | Adaptive multi‐degree‐of‐freedom in situ bioprinting robot for hair‐follicle‐inclusive skin repair: A preliminary study conducted in mice |
| Q55030497 | Anticancer nanoparticulate polymer-drug conjugate. |
| Q91213714 | Applications of decellularized extracellular matrix in bone and cartilage tissue engineering |
| Q114218112 | Baicalein self‐microemulsion based on drug–phospholipid complex for the alleviation of cytokine storm |
| Q55093481 | BioTM Buzz (Volume 3, Issue 1). |
| Q90677427 | BioTM Buzz (Volume 3, Issue 2) |
| Q58123265 | BioTM Buzz (Volume 3, Issue 3) |
| Q61453701 | BioTM Buzz (Volume 4, Issue 1) |
| Q100417590 | BioTM Buzz (Volume 5, Issue 3): The Future is Bright |
| Q64913209 | BioTM Buzz Volume 4, Issue 2. |
| Q90404026 | BioTM Buzz Volume 4, Issue 3 |
| Q92983360 | BioTM Buzz Volume 5, Issue 1 |
| Q95643291 | BioTM buzz (volume 5, issue 2) |
| Q53678388 | BioTM buzz. |
| Q55257274 | BioTM buzz. |
| Q55515511 | BioTM buzz. |
| Q91213728 | Biodegradable bioadhesive nanoparticle incorporation of broad-spectrum organic sunscreen agents |
| Q100417576 | Bioengineering & Translational Medicine: Year 2020 in review |
| Q55209384 | Biomimetic strategies for targeted nanoparticle delivery. |
| Q113928626 | Bio‐functional hydrogel with antibacterial and anti‐inflammatory dual properties to combat with burn wound infection |
| Q92983355 | CRISPR/Cas9-mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1-mutated breast cancer cells |
| Q90677446 | Clinical translation of microbe-based therapies: Current clinical landscape and preclinical outlook |
| Q51076259 | Controlling the surface-mediated release of DNA using 'mixed multilayers'. |
| Q98663133 | Current diagnostic tools for coronaviruses-From laboratory diagnosis to POC diagnosis for COVID-19 |
| Q95643287 | Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration |
| Q58124239 | Derivation of neural crest stem cells from human epidermal keratinocytes requires FGF-2, IGF-1, and inhibition of TGF-β1 |
| Q124959389 | Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood |
| Q53064170 | Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine. |
| Q64899019 | Detachment of ligands from nanoparticle surface under flow and endothelial cell contact: Assessment using microfluidic devices. |
| Q53882343 | Detection of ovulation, a review of currently available methods. |
| Q112700488 | Development of di(2-ethylhexyl) phthalate-containing thioglycolic acid immobilized chitosan mucoadhesive gel as an alternative hormone therapy for menopausal syndrome |
| Q61453254 | Device design methodology and formulation of a protein therapeutic for sustained release intraocular delivery |
| Q53712321 | Direct comparison of oligochaete erythrocruorins as potential blood substitutes. |
| Q53605099 | Dose enhancement and cytotoxicity of gold nanoparticles in colon cancer cells when irradiated with kilo- and mega-voltage radiation. |
| Q90404014 | Editorial: The launch phase of Bioengineering & Translational Medicine |
| Q50989161 | Emerging applications of exosomes in cancer therapeutics and diagnostics. |
| Q95643289 | Employing drug delivery strategies to create safe and effective pharmaceuticals for COVID-19 |
| Q58124236 | Encapsulation of mesenchymal stem cells in glycosaminoglycans-chitosan polyelectrolyte microcapsules using electrospraying technique: Investigating capsule morphology and cell viability |
| Q58127281 | Engineered E. coli Nissle 1917 for the reduction of vancomycin-resistant in the intestinal tract |
| Q50870950 | Engineered heparins as new anticoagulant drugs. |
| Q129181778 | Engineered in vivo and in vitro tumor model recapitulates vasculogenic mimicry signatures in melanoma |
| Q50870947 | Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis. |
| Q58123263 | Engineering clinical translation-Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference |
| Q90677420 | Engineering clinical translation-Introduction to Special Issue Dedicated to 2017 Bioengineering and Translational Medicine Conference |
| Q112750161 | Engineering elastic sealants based on gelatin and elastin-like polypeptides for endovascular anastomosis |
| Q110698750 | Engineering human skin model innervated with itch sensory neuron‐like cells differentiated from induced pluripotent stem cells |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q54991276 | Engineering nanoparticles to overcome barriers to immunotherapy. |
| Q51337287 | Engineering of a miniaturized, robotic clinical laboratory. |
| Q50943132 | Engineering of nanoparticle size via electrohydrodynamic jetting. |
| Q50895901 | Engineering responsive supramolecular biomaterials: Toward smart therapeutics. |
| Q90404011 | Engineering tissue-specific blood vessels |
| Q91213700 | Engineering, on-demand manufacturing, and scaling-up of polymeric nanocapsules |
| Q112716419 | Enhanced tumor cell killing by ultrasound after microtubule depolymerization |
| Q51008485 | Evaluating side effects of nanoparticle-mediated siRNA delivery to mesenchymal stem cells using next generation sequencing and enrichment analysis. |
| Q51055092 | Evaluation of Receptor-Ligand Mechanisms of Dual-Targeted Particles to an Inflamed Endothelium. |
| Q52724995 | Evolving trends in mAb production processes. |
| Q95643276 | Ex vivo isolated human vessel perfusion system for the design and assessment of nanomedicines targeted to the endothelium |
| Q112700487 | Exosomes derived from olfactory ensheathing cells provided neuroprotection for spinal cord injury by switching the phenotype of macrophages/microglia |
| Q123219790 | Extracellular matrix bioink boosts stemness and facilitates transplantation of intestinal organoids as a biosafe Matrigel alternative |
| Q90403987 | Facilitating plasmid nuclear delivery by interfering with the selective nuclear pore barrier |
| Q54942026 | Folate receptor-targeted aminoglycoside-derived polymers for transgene expression in cancer cells. |
| Q61454013 | Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics |
| Q56992437 | Harnessing nanostructured systems for improved treatment and prevention of HIV disease |
| Q58129507 | Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques |
| Q51076268 | High-throughput screening of clinically approved drugs that prime polyethylenimine transfection reveals modulation of mitochondria dysfunction response improves gene transfer efficiencies. |
| Q50995525 | Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines. |
| Q90677465 | How will the field of gene therapy survive its success? |
| Q52771103 | Human pluripotent stem cell-derived epicardial progenitors can differentiate to endocardial-like endothelial cells. |
| Q95643282 | Hydrogels in the clinic |
| Q50887651 | ICAM-1-Targeted Nanocarriers Attenuate Endothelial Release of Soluble ICAM-1, an Inflammatory Regulator. |
| Q51810666 | IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow. |
| Q55095891 | Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles. |
| Q58126555 | In silico analytico-mathematical interpretation of biopolymeric assemblies: Quantification of energy surfaces and molecular attributes via atomistic simulations |
| Q100417578 | In situ forming microporous gelatin methacryloyl hydrogel scaffolds from thermostable microgels for tissue engineering |
| Q112640976 | In-cytoplasm mitochondrial transplantation for mesenchymal stem cells engineering and tissue regeneration |
| Q95643284 | Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization |
| Q92983337 | Injectable supramolecular polymer-nanoparticle hydrogels enhance human mesenchymal stem cell delivery |
| Q51076249 | Integration of growth factor gene delivery with collagen-triggered wound repair cascades using collagen-mimetic peptides. |
| Q91213740 | Interpretation of the mechanism of action of antituberculosis drug bedaquiline based on a novel two-ion theory of energy coupling in ATP synthesis |
| Q55023208 | Intestinal mucoadhesive devices for oral delivery of insulin. |
| Q104518071 | Intradermal delivery of receptor-binding domain of SARS-CoV-2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice |
| Q94317452 | Introduction to Editorial Board Member: Professor Antonios (Tony) G. Mikos |
| Q55113842 | Introduction to Editorial Board Member: Professor Francis J. Doyle III. |
| Q58781018 | Introduction to Editorial Board Member: Professor Kristi S. Anseth |
| Q55067713 | Introduction to Editorial Board Member: Professor Mark E. Davis. |
| Q94076409 | Introduction to Editorial Board Member: Professor Mark R. Prausnitz |
| Q55486890 | Introduction to Editorial Board Member: Professor Paula T. Hammond. |
| Q55091547 | Introduction to Editorial Board Members: Dr. Raghunath Mashelkar. |
| Q55029625 | Introduction to Editorial Board Members: Prof Nicholas A. Peppas. |
| Q94399996 | Introduction to Editorial Board Members: Professor David A. Tirrell |
| Q55090855 | Introduction to Editorial Board Members: Professor Matthew V. Tirrell. |
| Q55091612 | Introduction to Special Issue: 2016 Translational Medicine and Bioengineering Conference. |
| Q55161740 | Introduction to special issue on "Nanoparticles in Medicine: Targeting, Optimization and Clinical Applications". |
| Q55496411 | Introduction to special issue on "Responsive Materials and Systems: Toward Smart and Precision Medications". |
| Q54966106 | Introduction to special issue: Bioengineered Therapeutics. The Next Generation of Drug Development. |
| Q54964565 | Introduction to the BioTM special issue "Nucleic Acid Delivery: Enabling the Drugs of Tomorrow". |
| Q52703982 | Ionic liquids for addressing unmet needs in healthcare. |
| Q58719342 | Issue Information - Table of Contents |
| Q61446714 | Issue Information - Table of Contents |
| Q94075499 | Issue Information – Table of Contents |
| Q94076419 | Issue Information – Table of Contents |
| Q94317461 | Issue Information – Table of Contents |
| Q94416886 | Issue Information – Table of Contents |
| Q94517320 | Issue Information – Table of Contents |
| Q112277432 | LINC00473-modified bone marrow mesenchymal stem cells incorporated thermosensitive PLGA hydrogel transplantation for steroid-induced osteonecrosis of femoral head: A detailed mechanistic study and validity evaluation |
| Q64940055 | Layer‐by‐layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum‐based drug resistance therapy in ovarian cancer. |
| Q90403999 | Leader cell PLCγ1 activation during keratinocyte collective migration is induced by EGFR localization and clustering |
| Q55077875 | Letter from AIChE President. |
| Q89823529 | Letter from the Editor |
| Q64957922 | Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma. |
| Q61456008 | Lipid nanoparticles silence tumor necrosis factor α to improve wound healing in diabetic mice |
| Q93091694 | Long-term therapeutic effect in nonhuman primate eye from a single injection of anti-VEGF controlled release hydrogel |
| Q92983325 | Manipulation of the dually thermoresponsive behavior of peptide-based vesicles through modification of collagen-like peptide domains |
| Q94399993 | Masthead & TOC |
| Q94400006 | Masthead & TOC |
| Q94402794 | Masthead & TOC |
| Q94402799 | Masthead & TOC |
| Q94402806 | Masthead & TOC |
| Q94402818 | Masthead & TOC |
| Q112080604 | Matrix stiffness mechanosensing modulates the expression and distribution of transcription factors in Schwann cells |
| Q50935948 | Mechanisms of Light-induced Liposome Permeabilization. |
| Q112347140 | Mesenchymal stem cell-inspired microgel scaffolds to control macrophage polarization |
| Q64887781 | Method of establishing breast cancer brain metastases affects brain uptake and efficacy of targeted, therapeutic nanoparticles. |
| Q52397658 | Microfluidic co-culture devices to assess penetration of nanoparticles into cancer cell mass. |
| Q51459366 | Microfluidics-based 3D cell culture models: Utility in novel drug discovery and delivery research. |
| Q64892049 | Microneedle‐based intradermal delivery of stabilized dengue virus. |
| Q112612624 | Mitochondrial transplantation therapy inhibit carbon tetrachloride-induced liver injury through scavenging free radicals and protecting hepatocytes |
| Q112700489 | Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment-mediated protein nanocages for enhancing cancer biotherapy |
| Q91213707 | Multivariate learning framework for long-term adaptation in the artificial pancreas |
| Q90677458 | Multivariate techniques enable a biochemical classification of children with autism spectrum disorder versus typically-developing peers: A comparison and validation study |
| Q61455125 | Nanocrystals: A perspective on translational research and clinical studies |
| Q61951682 | Nanoengineered thermoresponsive magnetic hydrogels for biomedical applications |
| Q100417574 | Nanoparticle-microglial interaction in the ischemic brain is modulated by injury duration and treatment |
| Q55003489 | Nanoparticles in the clinic. |
| Q90404021 | Nanoparticles in the clinic: An update |
| Q55105391 | Near-infrared light-sensitive liposomes for enhanced plasmid DNA transfection. |
| Q112346736 | Novel nanofibrous membrane-supporting stem cell sheets for plasmid delivery and cell activation to accelerate wound healing |
| Q100417588 | Oxidative pentose phosphate pathway and glucose anaplerosis support maintenance of mitochondrial NADPH pool under mitochondrial oxidative stress |
| Q100417565 | PRADA: Portable Reusable Accurate Diagnostics with nanostar Antennas for multiplexed biomarker screening |
| Q54959860 | Peptide delivery with poly(ethylene glycol) diacrylate microneedles through swelling effect. |
| Q55656986 | Peptide-Based Supramolecular Hydrogels for Delivery of Biologics. |
| Q112728280 | Personalized-induced neural stem cell therapy: Generation, transplant, and safety in a large animal model |
| Q92983319 | Phage display as a tool for vaccine and immunotherapy development |
| Q52839218 | Picoliter-volume inkjet printing into planar microdevice reservoirs for low-waste, high-capacity drug loading. |
| Q55169959 | Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4+ or CD8+ T cell activation. |
| Q91213733 | Polymeric curcumin nanoparticles by a facile in situ method for macrophage targeted delivery |
| Q50943002 | Polymeric nanoparticle-based delivery of TRAIL DNA for cancer-specific killing. |
| Q52388109 | RNA-Peptide nanoplexes drug DNA damage pathways in high-grade serous ovarian tumors. |
| Q55033529 | ROS-responsive drug delivery systems. |
| Q55233314 | Reduced arterial elasticity due to surgical skeletonization is ameliorated by abluminal PEG hydrogel. |
| Q51076263 | Reducing neuroinflammation by delivery of IL-10 encoding lentivirus from multiple-channel bridges. |
| Q95643265 | Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies |
| Q91213702 | Rescuing mesenchymal stem cell regenerative properties on hydrogel substrates post serial expansion |
| Q64997623 | Role of synergy and immunostimulation in design of chemotherapy combinations: An analysis of doxorubicin and camptothecin. |
| Q61865897 | Scalable synthesis and validation of PAMAM dendrimer--acetyl cysteine conjugate for potential translation |
| Q53465288 | Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation. |
| Q100417584 | Screening method to identify hydrogel formulations that facilitate myotube formation from encapsulated primary myoblasts |
| Q64881146 | Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches. |
| Q128688236 | Sex‐dependent improvement in traumatic brain injury outcomes after liposomal delivery of dexamethasone in mice |
| Q95643273 | Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow |
| Q55054164 | Soluble Collagen VI treatment enhances mesenchymal stem cells expansion for engineering cartilage. |
| Q50853038 | Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants. |
| Q92983349 | Sprayable and biodegradable, intrinsically adhesive wound dressing with antimicrobial properties |
| Q50904654 | Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment. |
| Q112700490 | Synergistic strategy with hyperthermia therapy based immunotherapy and engineered exosomes-liposomes targeted chemotherapy prevents tumor recurrence and metastasis in advanced breast cancer |
| Q55000902 | Synthetic bioreducible lipid-based nanoparticles for miRNA delivery to mesenchymal stem cells to induce neuronal differentiation. |
| Q50851448 | Synthetic nanoscale electrostatic particles as growth factor carriers for cartilage repair. |
| Q90677434 | TGF-β-responsive CAR-T cells promote anti-tumor immune function |
| Q55038951 | Targeting HPV-infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine. |
| Q95643268 | Targeting functionalized nanoparticles to activated endothelial cells under high wall shear stress |
| Q52724985 | The Wyss institute: A new model for medical technology innovation and translation across the academic-industrial interface. |
| Q92983330 | The assembly of integrated rat intestinal-hepatocyte cultures |
| Q100417572 | The effect of size, charge, and peptide ligand length on kidney targeting by small, organic nanoparticles |
| Q100417568 | The wasp venom antimicrobial peptide polybia-CP and its synthetic derivatives display antiplasmodial and anticancer properties |
| Q100417570 | Therapeutic potential of extracellular vesicle-associated long noncoding RNA |
| Q112295505 | Transcriptomic response of brain tissue to focused ultrasound-mediated blood-brain barrier disruption depends strongly on anesthesia |
| Q89823596 | Transcutaneous pollinosis immunotherapy using a solid-in-oil nanodispersion system carrying T cell epitope peptide and R848 |
| Q52724991 | Translation in cardiovascular stents and occluders: From biostable to fully degradable. |
| Q112289537 | Tripartite collaboration of blood-derived endothelial cells, next generation RNA sequencing and bioengineered vessel-chip may distinguish vasculopathy and thrombosis among sickle cell disease patients |
| Q51766271 | Tunable particles alter macrophage uptake based on combinatorial effects of physical properties. |
| Q112733546 | Two diverse carriers are better than one: A case study in α-particle therapy for prostate specific membrane antigen-expressing prostate cancers |
| Q115454332 | Ultrasound‐microbubble cavitation facilitates adeno‐associated virus mediated cochlear gene transfection across the round‐window membrane |
| Q90403993 | Understanding optical reflectance contrast for real-time characterization of epithelial precursor lesions |
| Q91213687 | Uptake and function of membrane-destabilizing cationic nanogels for intracellular drug delivery |
| Q54290026 | Virus-like particles: Next-generation nanoparticles for targeted therapeutic delivery. |
| Q52703980 | Visible light crosslinkable human hair keratin hydrogels. |
| Q110596358 | “Musical dish” efficiently induces osteogenic differentiation of mesenchymal stem cells through music derived micro‐stretch with variable frequency |
| P8375 | Crossref journal ID | Wikidata property example | P1855 |
Search more.